Old Web
English
Sign In
Acemap
>
authorDetail
>
Caitlin S Rees
Caitlin S Rees
Western General Hospital
Medicine
Biosimilar
Adalimumab
Cohort study
Internal medicine
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effectiveness and Safety of Adalimumab Biosimilar SB5 in IBD: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naieve SB5 Observational Cohorts
2021
Journal of Crohns & Colitis
Lauranne A.A.P. Derikx
Heather W Dolby
Nikolas Plevris
Laura Lucaciu
Caitlin S Rees
Mathew Lyons
S Siakavellas
Nathan Constantine-Cooke
Philip Jenkinson
Shanna Su
Claire OHare
Laura Kirckpatrick
Lynne M Merchant
Colin L. Noble
Ian D. Arnott
Gareth-Rhys Jones
Charlie W. Lees
Show All
Source
Cite
Save
Citations (1)
P330 Long-term outcomes following a switch from originator adalimumab to the biosimilar SB5 (Imraldi) in IBD
2021
Journal of Crohn's and Colitis
Lauranne A.A.P. Derikx
Heather W Dolby
Nikolas Plevris
Laura Lucaciu
Caitlin S Rees
Mathew Lyons
S Siakavellas
Nathan Constantine-Cooke
Colin L. Noble
Claire OHare
Lynne M Merchant
I. D. R. Arnott
G R Jones
C Lees
Show All
Source
Cite
Save
Citations (0)
1